1. Tentonin 3/TMEM150C regulates glucose-stimulated insulin secretion in pancreatic β-cells.
- Author
-
Wee J, Pak S, Kim T, Hong GS, Lee JS, Nan J, Kim H, Lee MO, Park KS, and Oh U
- Subjects
- Animals, Glucose Intolerance etiology, Glucose Intolerance metabolism, Insulin-Secreting Cells drug effects, Male, Membrane Potentials, Mice, Mice, Inbred C57BL, Mice, Knockout, Sweetening Agents pharmacology, Calcium metabolism, Glucose pharmacology, Glucose Intolerance pathology, Insulin Secretion, Insulin-Secreting Cells metabolism, Membrane Proteins physiology
- Abstract
Glucose homeostasis is initially regulated by the pancreatic hormone insulin. Glucose-stimulated insulin secretion in β-cells is composed of two cellular mechanisms: a high glucose concentration not only depolarizes the membrane potential of the β-cells by ATP-sensitive K
+ channels but also induces cell inflation, which is sufficient to release insulin granules. However, the molecular identity of the stretch-activated cation channel responsible for the latter pathway remains unknown. Here, we demonstrate that Tentonin 3/TMEM150C (TTN3), a mechanosensitive channel, contributes to glucose-stimulated insulin secretion by mediating cation influx. TTN3 is expressed specifically in β-cells and mediates cation currents to glucose and hypotonic stimulations. The glucose-induced depolarization, firing activity, and Ca2+ influx of β-cells were significantly lower in Ttn3-/- mice. More importantly, Ttn3-/- mice show impaired glucose tolerance with decreased insulin secretion in vivo. We propose that TTN3, as a stretch-activated cation channel, contributes to glucose-stimulated insulin secretion., Competing Interests: Declaration of interests U.O. and J.W. have a registered patent in the Republic of Korea for the use of Tentonin 3 for developing treatments of diabetes mellitus (KR-10-2019-0083428)., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF